Simplicity is all
In this issue of BioScience Today, Ellen Rossiter speaks to Professor Kawal Rhode about his work in the realm of biomedical engineering, his inspiration, motivation and why simplicity is all.
“Way back in school, we...
Reducing the risk of bio-contamination in gene, cell and CAR-T therapy
Bioquell’s Dr Rolf Hansen examines how the latest isolator systems create aseptic working conditions for reducing risk and keeping gene, cell and CAR-T therapies efficient, compliant and accurate, whilst also supporting biologics manufacturing expansion...
Top tips to safeguard your medtech in a competitive industry
Medical technology is one of the fastest growing, and most competitive, industries in the world.
With a thriving ecosystem of over 3,700 companies, 115,000 skilled workers, and a turnover of over £21 billon, the UK’s...
What is the best time to file a patent application?
Katherine Wright, Pharmaceutical Patent Attorney at Adamson Jones
Determining the best time to file a patent application is one of the first and sometimes one of the most difficult questions that patent applicants face, and...
Preparations for AI patenting in Europe
The current era of rapid technological development requires industry to be quick to respond to challenges and opportunities, with many choosing to exploit new AI technologies rather than wait to be disrupted by competitors.
Intellectual...
Europe is “failing” to deal with chronic digestive disease burden
Europe is currently failing to manage the increasing burden inflicted by chronic digestive diseases, according to leading digestive health experts.
A report, published today during the launch of MEP Digestive Health Group, reveals alarming issues,...
Engaging the patient as partner
Ceciel T. Rooker, President, IFFGD
There is growing recognition in the research community of the role of the patient as partner – not only in the outcomes of medical research, but in its practice, as...
Stay future-ready: Running parallel operations with a CDMO during clinical trials
Bringing a drug candidate through clinical trials is a challenging and high-risk process, since only 10% of candidates actually reach final approval. Both established pharma companies and small startups are often faced with this...
Forging advances in the treatment of respiratory diseases
In this issue of BioScience Today, we speak to Professor Martin Gosling, about the inspiration behind his work, what motivates him daily, and the advances in the treatment of respiratory diseases that he is...
Getting more out of our medicines – re-purposing drugs to improve patient care
Paul Chrisp, Programme Director Medicines and Technologies, NICE
Developing new medicines and then ensuring they are used appropriately is a costly and drawn out process. The NHS needs to make sure that alongside the development...
Helping everyone breathe easier – finding new approaches to treating respiratory disease
Everyone should be able to breathe clean air with healthy lungs, yet sadly far too many people continue to gasp for breath because of lung disease. In the UK, one in five people develop...
Patient capital is the key to unlocking growth in the life sciences sector
By Keith Morgan, CEO, British Business Bank
The British Business Bank, as the UK’s national economic development bank, has a mission to make finance markets for smaller businesses operate more effectively, enabling those businesses to...
Urban development is attracting leading scientists and ambitious companies to the north
Newcastle Helix is the UK’s biggest urban development of its kind outside of London and has entered its next phase of development.
The £350m flagship project, brings together a community of academics, industry leaders, businesses...
Cutting costs, saving time and doing away with needles: Laser technology promises a triple...
Blood tests: They’re not only extremely common and, let’s face it, not particularly popular with patients, they are also a huge drain on health service resources.
Blood samples make up a significant proportion of the...
Research finds three major failings in some apps used for the diagnosis of skin...
In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the...
Radiation in cancer diagnosis – keeping your enemies closer
It’s a remarkable paradox of cancer treatment that radiation, a well-known cause of cancer, is also a cornerstone treatment. Safe doses of radiation can also play a part in diagnosis. Scientists working within the...